Safe Implementation of Thrombolysis in Stroke Monitoring Study "SITS-MOST"

Completed

Phase N/A Results

Summary of Purpose

To compare the safety and efficacy of tissue plasminogen activator (TPA) administered in controlled clinical trials to that of TPA prescribed in routine clinical practice.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 September 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Boehringer Ingelheim GmbH

Trial Design

Non-controlled, observational study comparing outcomes of non-study patients to those participating in a controlled clinical trial.

Contacts

Not available